Home > Press > SYNBIOBETA SF 2013 The Conference For Synthetic Biology Startups, Industry and Investors
Abstract:
On November 15, 2013, SynBioBeta will once again be bringing together the synthetic biology community for the second annual SynBioBeta Conference at Mission Bay Conference Center UCSF.
The conference provides a venue for companies, both established and startups, investors and academics to meet, partner, exchange ideas and learn about the latest advances in the rapidly evolving field of synthetic biology. Some of the topics on the agenda are: Crowdfunding, Advances in Gene and Genome Synthesis, Scale-up in the Bioeconomy and Synthetic Biology VC Funding. The audience will also hear from new startups in the field, including nine companies visiting from the UK on a synthetic biology trade mission.
"We are now seeing an exponential growth in the number of synthetic biology startups year after year," says Dr. John Cumbers, founder of SynBioBeta. "As the cost of writing DNA falls, we see a range of new startup companies entering the synthetic biology market competing with a number of established players" "These companies range from those with new technologies for writing DNA such as Gen9 and DNA2.0, to companies making computer aided design (CAD) tools for genome design such as Teselagen, Genome Compiler and Benchling." "We also have a number of speakers from applications companies such as Dr. Paul Hill from Amyris, Dr. Harry Yim from Genomatica and Sean Ward from UK based Synthace, who will all be talking about scaling up their solutions for the production of high value chemicals. Dr. Mike Koeris from Sample6 technologies will also be giving an update on their innovative food safety biosensor, for which they just closed an $11M series B financing."
The conference will be followed by a cocktail reception and on Saturday, November 16, 2013, SynBioBeta will be presenting a Networking Brunch Cruise past the Golden Gate Bridge for anyone in the synthetic biology community to attend. For more information on the conference and the Brunch Cruise, please contact Lisa Comeau at 650-479-5011, or visit www.synbiobeta.com.
####
For more information, please click here
Contacts:
Lisa Comeau
Phone: 650-479-5011
Copyright © SynBioBeta, LLC
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Synthetic Biology
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||